Prevention Of Cognitive Decline In Patients With Neuronopathic Mucopolysaccharidosis Type Ii Treated By Intracerebroventricular Enzyme Replacement Therapy: 100-Week Results Of An Open-Label Phase 1/2 Study

MOLECULAR GENETICS AND METABOLISM(2021)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要